These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10759710)

  • 1. Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin.
    Harenberg J; Hoffmann U; Huhle G; Song XH; Wang LC
    Br J Haematol; 2000 Mar; 108(3):528-30. PubMed ID: 10759710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-exposure to recombinant (r)-hirudin in antihirudin antibody-positive patients with a history of heparin-induced thrombocytopenia.
    Harenberg J; Huhle G; Wang LC; Hoffmann U; Song XH
    Br J Haematol; 2000 May; 109(2):360-3. PubMed ID: 10848825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study].
    Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL
    Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 5. Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin.
    Song X; Huhle G; Wang L; Hoffmann U; Harenberg J
    Circulation; 1999 Oct; 100(14):1528-32. PubMed ID: 10510056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
    Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
    Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin.
    Huhle G; Geberth M; Hoffmann U; Heene DL; Harenberg J
    Gynecol Obstet Invest; 2000; 49(1):67-9. PubMed ID: 10629377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 10. A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study.
    Huhle G; Hoffmann U; Hoffmann I; Liebe V; Harenberg JF; Heene DL
    Thromb Res; 2000 Aug; 99(4):325-34. PubMed ID: 10963783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant therapy with recombinant hirudin in patients with thrombopenia induced by heparin].
    Schiele F; Vuillemenot A; Mouhat T; Kieffer Y; Anguenot T; Bernard Y; Bassand JP
    Presse Med; 1996 May 4-11; 25(16):757-60. PubMed ID: 8692751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance.
    Greinacher A; Eichler P; Albrecht D; Strobel U; Pötzsch B; Eriksson BI
    Blood; 2003 Apr; 101(7):2617-9. PubMed ID: 12393696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refludan: pharmacologic surveillance study].
    Winicki J
    Presse Med; 1998 Jun; 27 Suppl 2():31-2. PubMed ID: 9765664
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical utility of subcutaneous hirudins.
    Deitcher SR
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S27-31. PubMed ID: 14593980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia.
    Bauer M; Koster A; Pasic M; Weng Y; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):191-2. PubMed ID: 10384203
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
    Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
    Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding after intermittent or continuous r-hirudin during CVVH.
    Kern H; Ziemer S; Kox WJ
    Intensive Care Med; 1999 Nov; 25(11):1311-4. PubMed ID: 10654220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.